Secular trend and risk factors for antimicrobial resistance in escherichia coli isolates in Switzerland 1997-2007

Infection

Volumn 37, Issue 6, 2009, Pages 534-539

  Blaettler, L ^a   Mertz, D ^a   Frei, R ^a   Elzi, L ^a   Widmer, A F ^a   Battegay, M ^a   Fluckiger U ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; CIPROFLOXACIN; COTRIMOXAZOLE; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL COLONIZATION; BACTERIUM ISOLATE; ESCHERICHIA COLI; GENERAL PRACTITIONER; HOSPITAL INFECTION; NONHUMAN; RETROSPECTIVE STUDY; RISK FACTOR; SEX DIFFERENCE; SWITZERLAND; URINARY TRACT INFECTION;

ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, BACTERIAL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FEMALE; HOSPITALS, UNIVERSITY; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; SWITZERLAND; URINARY TRACT INFECTIONS; YOUNG ADULT;

EID: 77249167631     PISSN: 03008126     EISSN: None     Source Type: Journal    
DOI: 10.1007/s15010-009-8457-0     Document Type: Article

References (30)

1. W.E. Stamm S.R. Norrby 2001 Urinary tract infections: disease panorama and challenges J Infect Dis 183 S1 4 10.1086/318850 11171002 (Pubitemid 32174135)
2. S. Hillier J. Bell M. Heginbothom Z. Roberts F. Dunstan A. Howard B. Mason C.C. Butler 2006 When do general practitioners request urine specimens for microbiology analysis? The applicability of antibiotic resistance surveillance based on routinely collected data J Antimicrob Chemother 58 1303 1306 10.1093/jac/dkl432 1:CAS:528:DC%2BD28Xht1OgsrzI 17062608 (Pubitemid 44884159)
3. R. Colgan J.R. Johnson M. Kuskowski K. Gupta 2008 A prospective study of risk factors for trimethoprim-sulfamethoxazole resistance in acute uncomplicated cystitis Antimicrob Agents Chemother 167 2201 2206
4. M.E. Falagas M. Polemis V.G. Alexiou A. Marini-Mastrogiannaki J. Kremastinou A.C. Vatopoulos 2008 Antimicrobial resistance of Esherichia coli urinary isolates from primary care patients in Greece Med Sci Monit 14 CR75 CR79 18227764
5. T.M. Hooton D. Scholes K. Gupta A.E. Stapleton P.L. Roberts W.E. Stamm 2005 Amoxicillin-clavulanate vs ciprofloxacin for the treatment of uncomplicated cystitis in women: a randomized trial JAMA 293 949 955 10.1001/jama.293.8.949 1:CAS:528:DC%2BD2MXhsFCgtLw%3D 15728165 (Pubitemid 40271126)
6. K. Gupta T.M. Hooton W.E. Stamm 2001 Increasing antimicrobial resistance and the management of uncomplicated communityacquired urinary tract infections Ann Intern Med 135 41 50 1:STN:280:DC%2BD3MvgsVWisg%3D%3D 11434731 (Pubitemid 32619282)
7. J.A. Karlowsky L.J. Kelly C. Thornsberry M.E. Jones D.F. Sahm 2002 Trends in antimicrobial resistance among urinary tract infection isolates of Escherichia coli from female outpatients in the United States Antimicrob Agents Chemother 46 2540 2545 10.1128/AAC.46.8.2540-2545.2002 1:CAS:528: DC%2BD38XlsFGit7s%3D 12121930 (Pubitemid 34793461)
8. J.I. Alos M.G. Serrano J.L. Gomez-Garces J. Perianes 2005 Antibiotic resistance of Escherichia coli from community-acquired urinary tract infections in relation to demographic and clinical data Clin Microbiol Infect 11 199 203 10.1111/j.1469-0691.2004.01057.x 1:CAS:528:DC%2BD2MXjtVGqsbo%3D 15715717 (Pubitemid 40352766)
9. E.S. Huang R.S. Stafford 2002 National patterns in the treatment of urinary tract infections in women by ambulatory care physicians Arch Intern Med 162 41 47 10.1001/archinte.162.1.41 11784218
10. J.W. Warren E. Abrutyn J.R. Hebel J.R. Johnson A.J. Schaeffer W.E. Stamm 1999 Guidelines for antimicrobial treatment of uncomplicated acute bacterial cystitis and acute pyelonephritis in women. Infectious Diseases Society of America (IDSA) Clin Infect Dis 29 745 758 10.1086/520427 1:CAS:528: DyaK1MXnsVWhtLY%3D 10589881
11. Y. Taur M.A. Smith 2007 Adherence to the Infectious Diseases Society of America guidelines in the treatment of uncomplicated urinary tract infection Clin Infect Dis 44 769 774 10.1086/511866 17304445 (Pubitemid 46365298)
12. W.E. Stamm 2007 Evaluating guidelines Clin Infect Dis 44 775 776 10.1086/511878 17304446 (Pubitemid 46365299)
13. K. Gupta T.M. Hooton W.E. Stamm 2005 Isolation of fluoroquinoloneresistant rectal Escherichia coli after treatment of acute uncomplicated cystitis J Antimicrob Chemother 56 243 246 10.1093/jac/dki169 1:CAS:528:DC%2BD2MXmsV2itLg%3D 15911548 (Pubitemid 41418367)
14. C. Gagliotti L. Nobilio M.L. Moro 2007 Emergence of ciprofloxacin resistance in Escherichia coli isolates from outpatient urine samples Clin Microbiol Infect 13 328 331 10.1111/j.1469-0691.2006.01615.x 1:CAS:528:DC%2BD2sXjsVKktrk%3D 17391392 (Pubitemid 46603368)
15. B. Becnel R.L. Atmar G.L. Randall R.J. Hamill D. Steffen L. Zechiedrich 2008 Increased fluoroquinolone resistance with time in Escherichia coli from >17,000 patients at a large county hospital as a function of time, culture site, age, sex, and location BMC Infect Dis 8 4 10.1186/1471-2334-8-4 (Pubitemid 351338207)
16. H. Arslan O.K. Azap O. Ergonul F. Timurkaynak 2005 Risk factors for ciprofloxacin resistance among Escherichia coli strains isolated from community-acquired urinary tract infections in Turkey J Antimicrob Chemother 56 914 918 10.1093/jac/dki344 1:CAS:528:DC%2BD2MXhtFCjtLbJ 16174685 (Pubitemid 41631917)
17. M.R. Sannes E.A. Belongia B. Kieke K. Smith A. Kieke M. Vandermause J. Bender C. Clabots P. Winokur J.R. Johnson 2008 Predictors of antimicrobial-resistant Escherichia coli in the feces of vegetarians and newly hospitalized adults in Minnesota and Wisconsin J Infect Dis 197 430 434 10.1086/525530 18184093 (Pubitemid 351263425)
18. D.C. Sandel C.T. Wang S. Kessler 2002 Urinary tract infections and a multidrug-resistant Escherichia coli clonal group N Engl J Med 346 535 536 10.1056/NEJM200202143460717 11844861 (Pubitemid 34441752)
19. L.C. McDonald F.J. Chen H.J. Lo H.C. Yin P.L. Lu C.H. Huang P. Chen T.L. Lauderdale M. Ho 2001 Emergence of reduced susceptibility and resistance to fluoroquinolones in Escherichia coli in Taiwan and contributions of distinct selective pressures Antimicrob Agents Chemother 45 3084 3091 10.1128/AAC.45.11.3084-3091.2001 1:CAS:528:DC%2BD3MXnvF2jsb0%3D 11600360 (Pubitemid 32988832)
20. P.D. Brown A. Freeman B. Foxman 2002 Prevalence and predictors of trimethoprim-sulfamethoxazole resistance among uropathogenic Escherichia coli isolates in Michigan Clin Infect Dis 34 1061 1066 10.1086/339491 1:CAS:528:DC%2BD38XjsFyjsrw%3D 11914994 (Pubitemid 34289678)
21. S. Blot D. Vandijck K. Vandewoude P. Depuydt D. Vogelaers R. Peleman 2007 Comment on: impact of antibiotic resistance and of adequate empirical antibiotic treatment in the prognosis of patients with Escherichia coli bacteraemia J Antimicrob Chemother 60 1402 10.1093/jac/dkm379 1:CAS:528:DC%2BD2sXhtlKmt7bF 17913718 (Pubitemid 350168343)
22. G. Peralta M.B. Sanchez J.C. Garrido I. De Benito M.E. Cano L. Martinez-Martinez M.P. Roiz 2007 Impact of antibiotic resistance and of adequate empirical antibiotic treatment in the prognosis of patients with Escherichia coli bacteraemia J Antimicrob Chemother 60 855 863 10.1093/jac/dkm279 1:CAS:528:DC%2BD2sXht1ygtbnN 17644532 (Pubitemid 47434266)
23. Hindler JF, Evangelista AT, Jenkins SG, Johnston J, Master R, McGowan Jr. JE, Stelling J: Analysis and presentation of cumulative antimicrobial susceptibility test data; approved guideline (2nd edn). Clinical and Laboratory Standards Institute, Wayne, PA 2005.
24. S. Nys P.H. Terporten J.A. Hoogkamp-Korstanje E.E. Stobberingh 2008 Trends in antimicrobial susceptibility of Escherichia coli isolates from urology services in The Netherlands (1998-2005) J Antimicrob Chemother 62 126 132 10.1093/jac/dkn151 1:CAS:528:DC%2BD1cXnt1Snurk%3D 18417487 (Pubitemid 351865884)
25. G. Kahlmeter 2003 Prevalence and antimicrobial susceptibility of pathogens in uncomplicated cystitis in Europe. The ECO.SENS study Int J Antimicrob Agents 22 Suppl2 49 52 10.1016/S0924-8579(03)00229-2 14527771 (Pubitemid 37188486)
26. M. Filippini G. Masiero K. Moschetti 2006 Socioeconomic determinants of regional differences in outpatient antibiotic consumption: evidence from Switzerland Health Policy 78 77 92 10.1016/j.healthpol.2005.09.009 16290129 (Pubitemid 44108323)
27. M. Ferech S. Coenen S. Malhotra-Kumar K. Dvorakova E. Hendrickx C. Suetens H. Goossens 2006 European surveillance of antimicrobial consumption (ESAC): outpatient quinolone use in Europe J Antimicrob Chemother 58 423 427 10.1093/jac/dkl183 1:CAS:528:DC%2BD28Xotl2ls7o%3D 16735418 (Pubitemid 44294958)
28. P. Karpanoja S.T. Nyberg M. Bergman T. Voipio P. Paakkari P. Huovinen H. Sarkkinen 2008 Connection between trimethoprimsulfamethoxazole use and resistance in Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis Antimicrob Agents Chemother 52 2480 2485 10.1128/AAC.01118-07 1:CAS:528:DC%2BD1cXot1Ohsr0%3D 18443116 (Pubitemid 351915679)
29. J.M. Stelling K. Travers R.N. Jones P.J. Turner T.F. O'Brien S.B. Levy 2005 Integrating Escherichia coli antimicrobial susceptibility data from multiple surveillance programs Emerg Infect Dis 11 873 882 15963282
30. D.A. Talan A. Krishnadasan F.M. Abrahamian W.E. Stamm G.J. Moran 2008 Prevalence and risk factor analysis of trimethoprim-sulfamethoxazole- and fluoroquinolone-resistant Escherichia coli infection among emergency department patients with pyelonephritis Clin Infect Dis 47 1150 1158 10.1086/592250 18808361